Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, will present new data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting. The data, which ...

Please replace the release with the following corrected version due to multiple revisions. The updated release reads: HANSHOW STRENGTHENS GLOBAL ECOSYSTEM BY PARTNERING WITH GLINTT LIFE AND SHOPREME TO DRIVE SMART RETAIL DIGITALIZATION Hanshow, a global leader in digital retail solutions, is deepening its global ecosystem through strategic collaborations that connect local market expertise with advanced retail technology. The latest partnerships bring together Glintt—a technology and dist...

Belden Inc. (NYSE: BDC), a leading global provider of complete connection solutions, proudly announces the inauguration of its Pune Plant 2, a significant milestone in the company’s ongoing commitment to innovation, operational excellence and sustainable growth. The inauguration ceremony was led by Dr. Ashish Chand, Belden’s President and CEO, alongside the senior leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2025092...